Who
David E. Wheadon
Director
Company insider
Files Form 4 as: Director, Vaxart; Director, Sotera Health; Director, Indivior Pharmaceuticals; Director, Seaport Therapeutics; Director, Karuna Therapeutics; Director, ChemoCentryx; Director, Assertio Holdings; Director, Assertio Therapeutics.
In numbers
- Trades disclosed
- 44
- Buys
- 1
- Sells
- 0
- Bought
- $125K
- Sold
- $0
- Companies
- 8
- Companies where not an officer
- 8
- First trade
- 28 Sep 2019
- Last trade
- 16 Jul 2026
- Last filed
- 17 Jul 2026
Companies traded
Activity over time
1 Jan – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Jul 2026filed 17 Jul 2026 | VaxartBiotechnology | SEC FORM 4 Code A | —39,400 at $0.00 | filing |
| 16 Jul 2026filed 17 Jul 2026 | Vaxartoption or derivative · Biotechnology | SEC FORM 4 Code A | —78,700 at $0.00 | filing |
| 16 Jul 2026filed 17 Jul 2026 | Vaxartoption or derivative · Biotechnology | SEC FORM 4 Code A | —78,700 at $0.00 | filing |
| 16 Jul 2026filed 17 Jul 2026 | VaxartBiotechnology | SEC FORM 4 Code A | —39,400 at $0.00 | filing |
| 22 May 2026filed 27 May 2026 | SHC Sotera HealthProviders & Facilities | SEC FORM 4 Code A | —14,970 at $0.00 | filing |
| 22 May 2026filed 27 May 2026 | SHC Sotera HealthProviders & Facilities | SEC FORM 4 Code A | —14,970 at $0.00 | filing |
| 13 May 2026filed 14 May 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —10,430 at $0.00 | filing |
| 13 May 2026filed 14 May 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —10,430 at $0.00 | filing |
| 30 Apr 2026filed 4 May 2026 | SPTX Seaport Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,258 at $0.00 | filing |
| 30 Apr 2026filed 4 May 2026 | SPTX Seaport Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,258 at $0.00 | filing |
| 26 Jan 2026filed 28 Jan 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —5,955 at $0.00 | filing |
| 26 Jan 2026filed 28 Jan 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —5,955 at $0.00 | filing |
| 5 Jan 2026filed 7 Jan 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Bought | $63K1,771 at $35.39 | filing |
| 5 Jan 2026filed 7 Jan 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Bought | $63K1,771 at $35.39 | filing |
| 13 Jun 2025filed 16 Jun 2025 | Vaxartoption or derivative · Biotechnology | SEC FORM 4 Code A | —95,400 at $0.00 | filing |
| 13 Jun 2025filed 16 Jun 2025 | VaxartBiotechnology | SEC FORM 4 Code A | —16,000 at $0.00 | filing |
| 22 May 2025filed 27 May 2025 | SHC Sotera HealthProviders & Facilities | SEC FORM 4 Code A | —19,132 at $0.00 | filing |
| 11 Jun 2024filed 12 Jun 2024 | Vaxartoption or derivative · Biotechnology | SEC FORM 4 Code A | —95,400 at $0.00 | filing |
| 11 Jun 2024filed 12 Jun 2024 | VaxartBiotechnology | SEC FORM 4 Code A | —16,000 at $0.00 | filing |
| 24 May 2024filed 29 May 2024 | SHC Sotera HealthProviders & Facilities | SEC FORM 4 Code A | —20,089 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.